IceCure Medical Ltd. (ICCM) Earnings Call Analysis
NASDAQ · Healthcare · Medical Devices
Earnings Reports
-
IceCure Medical (ICCM) Q1 2026: North America Sales Surge 84% as FDA Clearance Unlocks Adoption
May 13, 2026
-
IceCure Medical (ICCM) Q4 2025: U.S. Commercial Team to Triple as FDA Clearance Spurs Demand
March 18, 2026
-
IceCure Medical (ICCM) Q3 2025: FDA Breast Cancer Authorization Unlocks 200,000-Patient U.S. Market
November 26, 2025